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Background: One of the most important manifestations of perinatal asphyxia is the occurrence of seizures, which
are treated with antiepileptic drugs, such as carbamazepine. These early seizures, combined with pharmacological
treatments, may influence the development of dopaminergic neurotransmission in the frontal cortex. This study
aimed to determine the extracellular levels of dopamine and its main metabolite DOPAC in 30-day-old rats that
had been asphyxiated for 45 min in a low (8%) oxygen chamber at a perinatal age and treated with daily doses
of carbamazepine. Quantifications were performed using microdialysis coupled to a high-performance liquid
chromatography (HPLC) system in basal conditions and following the use of the chemical stimulus.
Results: Significant decreases in basal and stimulated extracellular dopamine and DOPAC content were observed in
the frontal cortex of the asphyxiated group, and these decreases were partially recovered in the animals administered
daily doses of carbamazepine. Greater basal dopamine concentrations were also observed as an independent effect of
carbamazepine.
Conclusions: Perinatal asphyxia plus carbamazepine affects extracellular levels of dopamine and DOPAC in the frontal
cortex and stimulated the release of dopamine, which provides evidence for the altered availability of dopamine in
cortical brain areas during brain development.
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Perinatal asphyxia (PA) is a principal cause of long-term
neurological disability [1], and its severity appears to de-
pend on the intensity of the initial asphyxial event
(within the moderate to severe in range). PA can pro-
duce secondary brain damage related to the develop-
ment of attention deficit hyperactivity disorder (ADHD)
[2,3] and schizophrenia [4], and both of these diseases
are related to altered dopaminergic neurotransmission
[5,6]. Seizures are a common response to primary insult
that remain after the neonatal period [7-9] and are
treated with antiepileptic drugs (AED), such as carba-
mazepine (CBZ) [10-12], to avoid the consolidation of
the epileptic focus. Multiple studies have investigated* Correspondence: sjlopezperez@gmail.com
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unless otherwise stated.the effects of PA on the cellular environment, behavior
and development [13-21]; however, little is known about
the neurochemical brain response to the combination of
PA and long-term antiepileptic medical treatment. CBZ
has a tricyclic structure [22] and belongs to the first gen-
eration of anticonvulsive drugs. The use of CBZ is con-
sidered a good treatment choice for various types of
epilepsy due to its effectiveness and high tolerance. CBZ
has also been used with varying results in the treatment
of neuropathic pain [23] and psychiatric disorders [24].
CBZ interacts with different types of membrane recep-
tors and voltage-dependent sodium channels [11] and,
consequently, prevents synchronized high-frequency fir-
ing [25]. Another effect of CBZ is mediated through an
interaction with voltage-sensitive Ca2+ channels that in-
fluence glutamate release in hippocampus [26].
Dopamine (DA) is a principal catecholaminergic neuro-
transmitter that is synthesized by tyrosine hydroxylase
(TH) and aromatic amino acid decarboxylase [27], activatesntral. This is an Open Access article distributed under the terms of the Creative
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graded by monoamino-oxidase to 3,4-dihydroxypheny-
lacetic acid (DOPAC) or catechol-o-methyl transferase
to homovanillic acid (HVA) [28]. Previous evidence
suggests that DA release is significantly increased during
anoxia in a rat-pup model [29,30] and that DA content
is decreased in mesostriatal/mesolimbic homogenates of
4-week-old rats with PA [31]. Decreases in DA levels
have also been observed in dialysates from the striata of
3- and 6-month-old rats that have been asphyxiated at
birth [16,32]. In the mammal brain, one primary dopa-
minergic system is the mesocortical pathway, which in-
cludes cell bodies in the ventral tegmental area (VTA)
and synaptic terminals in the frontal and medial cortical
areas. Additionally, the mesocortical pathway is related
to working and episodic memory, impulsivity control and
mood stabilization [20]. Cognitive impairment, ADHD
and schizophrenia-related symptoms are related to this
dopaminergic system [33-36].
In the present work, we analyzed basal and stimu-
lated DA and DOPAC extracellular contents in the
frontal cortices of 30-day-old rats that had been as-
phyxiated in the early perinatal period and were re-
ceiving chronic CBZ treatment. Significant decreases
were observed in basal and stimulated extracellular
DA and DOPAC content in the frontal cortices of
the asphyxiated group, and a partial recovery was ob-
served in the animals that were receiving daily doses
of CBZ. Additionally, CBZ elevated basal DA concen-
trations in the control animals.
Methods
Animals
Pregnant female Wistar rats were maintained in individ-
ual cages on a 12:12 h light:dark cycle with ad libitum
access to water and food. At birth, the litters were ad-
justed to comprise eight male pups. All pups remained
with their mother until postnatal day (PD) 30. The animal
procedures were conducted according to the National
Regulations on Health Research matters (Mexico) and
directive 86/609/EEC for animal experiments. All ef-
forts were made to minimize animal suffering and the
number of animals used.
Experimental groups
At PD11, the pups were assigned to one of the following
experimental groups: the control group (without ma-
nipulation; the animals remained with their mother the
entire time); the CBZ group (received daily doses of
50 mg/kg CBZ dissolved in distilled water via oral admin-
istration from PD11 to PD30); the PA group (asphyxiated
at PD11); and the PA + CBZ group (asphyxiated at PD11
and treated with daily doses of 50 mg/kg CBZ dissolved
in distilled water via oral administration until PD30).Asphyxia induction
The PD11 pups assigned to the PA and PA +CBZ groups
were placed in small Plexiglas cage (10×10×10 cm) with a
sealable lid. An oxygen sensor was coupled to a lateral wall
(Maxtec Inc., Salt Lake, USA) and connected through an
interface (Pasco Scientific, CA, USA) to a computer. The
animals were subjected to asphyxia conditions with an
8% O2/92% N2 gas mixture for 45 min and then main-
tained for 15 min in the cage under normoxic condi-
tions (reperfusion period). The pups were subsequently
returned to their litter, where they remained until PD30.
During the asphyxia period, the pups’ behaviors were re-
corded by video and subsequently analyzed by a spotter
who was blind to the experimental conditions.
Microdialysis procedure
When the previously asphyxiated animals reached PD30,
they were subjected to a stereotaxic surgery to insert
a microdialysis probe (CMA7, 7-mm shaft length and
2-mm membrane length, 6-kDa cut off, mean recov-
ery 32 ± 5.6%) into frontal cortex (AP: 3.2 mm, L: 2.8 mm
and D: −3 mm relative to bregma under isoflurane
anesthesia). Throughout the experiment, the probe was
perfused with oxygenated Krebs-Ringer solution (all con-
centrations are in mM: NaCl 118; KCl 4; KH2PO4 1.25;
MgSO4 1.17; CaCl2 2.2; NaHCO3 25; and glucose 10).
Once the procedure was completed, the anesthesia was re-
moved, and after an equilibration period of 2 h, dialysis
fractions were collected (flow rate of 2.5 μl/min, one
sample every three min) according to the following
experimental protocol: fraction 1–2, basal conditions
(Krebs-Ringer solution); fraction 3–4, stimulating condi-
tions (20 mM 4-AP in Krebs-Ringer solution via reverse
microdialysis through the same probe with 15 μg of 4-AP
measured and dispensed into the brain); and fraction 5–
13, return to basal conditions (Krebs-Ringer solution).
The fractions were collected in an antioxidant solution
(0.4 mM sodium metabisulfite in 0.1 M perchloric acid)
and stored at −20°C until the DA and DOPAC content
quantifications were performed by HPLC. After each ex-
periment, the animal was deeply anaesthetized with nem-
butal and transcardially perfused with phosphate buffer
(0.1 M PBS, pH 7.4), followed by 4% paraformaldehyde.
The brains were obtained and post-fixed for 48 h at 4°C,
and 40-μm-thick coronal sections were excised and
stained with cresyl violet to ensure the proper location
of the guide cannula in right frontal cortex. Animals
with incorrectly placed cannulae were excluded from the
analyses.
DA and DOPAC measurements
The samples were analyzed for DA and DOPAC content
in a HPLC system using electrochemical detection that
consisted of an isocratic pump (Waters Corporation,
Figure 1 Basal extracellular levels of DA and DOPAC. The
measurements were made on PD30 from rats that had been
asphyxiated at PD11 in the control group (CTL), carbamazepine-
treated group (CBZ), asphyxiated group (PA) and asphyxiated plus
carbamazepine-treated group (PA + CBZ). *p < 0.05 vs. CTL for DA;
∞p < 0.05 vs. CTL for DOPAC.▽p < 0.05 PA + CBZ group vs. PA
group for DA; ⊗p < 0.05 PA + CBZ group vs. PA group for DOPAC.
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an RP-18 column (Waters Corporation, Milford, MA,
U.S.A., Xterra, 5 μM particle size, 2.1x100 mm, Waters),
and an amperometric detector (BAS Inc., West Lafayette,
IN, U.S.A., LC-4B, oxidation potential 0.5 V). The elution
medium was composed of 2.2 mM octanesulfonic acid
sodium, 14.7 mM sodium phosphate, 30 mM sodium cit-
rate, 0.027 mM EDTA (pH 3.5), and 4% acetonitrile. The
amperometric detector signal was digitalized with eDAQ
Power Chrome software (eDAQ Inc., Colorado Springs,
CO, U.S.A., version 2.6.3). In all of these conditions,
the DA and DOPAC elutions were achieved at 4.5
and 7.5 min, respectively, and the limit of detection for
both molecules was 1.25 nM.
Statistical analyses
The basal concentrations of DA and DOPAC are re-
ported in nanomolar concentrations (mean ± SD). Sig-
nificant differences between the groups were estimated
with one-way ANOVA tests, followed by Tukey’s post-
tests. The temporal course and stimulated extracellular
DA and DOPAC levels are expressed as percentages of
the control basal group, for which the mean value of the
three first fractions was considered 100%. The differ-
ences between the basal and stimulated fractions were
estimated using one-way ANOVA tests, followed by
Dunnett’s post-tests, and the specific differences between
groups were estimated via Tukey’s post-tests. In all cases,
statistical significance was considered at p < 0.05, and
the tests were performed with the GraphPad Prism soft-
ware, version 5.00, for Windows (GraphPad Software,
San Diego CA, U.S.A.).
Results
Behavioral observations during the induction of asphyxia
During the asphyxia procedure, the pups exhibited the
following behaviors 2–3 min after asphyxia onset: gasp-
ing, sudden jumps, repetitive head tremors, and forepaw
automatisms. By the end of asphyxia period, the pups
were cold and had pale skin colorations compared with
the control animals. The temperature and skin color
were recovered in the following 4–5 hours. In contrast,
the control pups placed in the same cage for the same
period of time exhibited quiet constant breathing, nor-
mal temperature and skin color and no indications of
any of the asphyxia behaviors described above.
Extracellular measurements of basal DA and DOPAC
The basal extracellular DA and DOPAC levels mea-
sured in the control groups were 7.85 ± 1.35 nM and
5.09 ± 1.28 nM (n = 12), respectively. Compared with the
control group, the CBZ-treated group exhibited signifi-
cant increases in DA (7.85 ± 1.35 nM for CTL vs. 19.07 ±
3.06 nM for CBZ) and DOPAC content (5.09 ± 1.28 nMfor CTL vs. 11.81 ± 0.97 nM for CBZ), whereas PA de-
creased DA (4.40 ± 0.89 nM for PA) and DOPAC (3.31 ±
0.69 nM for PA) content. Finally, the pups that were as-
phyxiated and treated with CBZ exhibited recoveries of
extracellular DA (10.33 ± 1.87 nM) and DOPAC (6.20 ±
0.81 nM) to slightly higher levels than those of the con-
trol group (Figure 1).
Extracellular measurement of stimulated DA and DOPAC
To stimulate DA release, a sub-convulsive dose of 4-
aminopyridine (4-AP) was administered via a reverse
dialysis procedure into frontal cortex. Figure 2a shows
the temporal course of DA release. The control group
exhibited an expected increase in DA following 4-AP in-
fusion in the tissue, followed by an elevated extracellular
concentration for at least the subsequent 20 min. Inter-
estingly, the animals that were chronically treated with
CBZ did not exhibit any increase in the extracellular
concentration of DA, although the basal levels of this
group were higher than that of the control group. How-
ever, the animals that had been asphyxiated at PD11
exhibited a temporal profile that involved low extracellu-
lar concentrations compared with the control group,
whereas the asphyxiated animals that had been chronic-
ally treated with CBZ recovered extracellular DA to a
level that was significantly higher than that of the PA
group (Figure 2a).
In contrast, the control group exhibited the expected
4-AP-induced increase in DOPAC; the DA response was
somewhat temporally delayed, and higher levels were
observed until the end of collection. The CBZ group
exhibited a higher basal level (relative to the control
group), and a transitory peak was induced by the 4-AP
infusion. The PA group exhibited a significant reduction
Figure 2 Temporal courses of DA in (a) and DOPAC (b). Microdialysates were obtained at PD30 from rats that had been asphyxiated on PD11
in the control group (CTL), carbamazepine-treated group (CBZ), asphyxiated group (PA) and asphyxiated plus carbamazepine-treated group (PA + CBZ).
Each fraction represents a 3 min sample, and the values are presented as percentages of the basal period of the CTL group, which was calculated by
taking the mean of the first three fractions as 100%. *p < 0.05 each fraction vs. its baseline.
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peak was induced following the infusion of 4-AP; how-
ever, no further differences were observed with respect
to basal DOPAC levels. Chronic CBZ administration in-
duced a significant elevation in extracellular DOPAC
level and a small and transient response to 4-AP that
quickly returned to basal levels (Figure 2b).
Discussion
Asphyxia at birth causes a severe energetic crisis in the
brain, which strongly depends on oxygen supply for
optimal functioning. Unfortunately, asphyxia is not a
fully predictable condition, and identifying strategies for
possible delayed complications, such as seizures [37],
ADHD and schizophrenia [38], is necessary. The use of
hypothermia has been considered a promising strategy
and has produced good results with several experimental
approaches [1,39]; however, its implementation is not
possible in most countries. In contrast, AEDs, such as
CBZ, have long been used as the first line of action in
the control and prevention of the seizures associated
with PA. Previous studies have explained the generation
of short-term seizures caused by PA and related oxygen
deprivation to early EEG abnormalities [40], the partici-
pation of glutamate receptors [41] and high extracellular
glutamate levels in the brain tissue during asphyxia [42].
These abnormalities have also been associated with the
complex metabolic cascades activated in response to in-
sult to cause ROS production [43] and changes in
neurochemical markers [42] and gene expression [44].
Altogether, these alterations may favor the perpetuation
of the initial damage and thus promote conditions favor-
able for subsequent changes to neurotransmitter sys-
tems, including the mesocortical dopaminergic system,
which is related to the hallmarks of ADHD and schizo-
phrenia. However, in clinical conditions, pediatric patients
with PA are subjected to pharmacological management,
and the information regarding the neurochemical re-
sponses of neurotransmitter systems that are relevant to
brain function during and after such pharmacological
treatment is insufficient. In this context, this study aimed
to analyze basal and stimulated DA and DOPAC extracel-
lular contents in the frontal cortex of 30-day-old rats that
had been asphyxiated in the early perinatal period and
were receiving chronic CBZ treatment. To our knowledge,
there are no previous reports related to the combined ef-
fects of PA and CBZ on DA cortical release.
The animals treated with CBZ exhibited increases in
basal DA and DOPAC concentrations. These effects
contrast with the data available in the literature because
CBZ is well known to inhibit voltage-activated sodium
channels and thus diminish high-frequency neuronal fir-
ing [45]. Additionally, CBZ interferes with L-type cal-
cium currents [26]. These observations suggest that CBZshould reduce the release of neurotransmitters. However,
CBZ may not exert such an effect on dopaminergic neu-
rons. Additionally, previous evidence suggests that DA
can be released in a calcium-independent manner in
both synaptosomes and striatum slices [46,47], even
when calcium channels are blocked [48], which accords
with the results reported here.
When the basal extracellular DA and DOPAC concen-
trations were measured in the frontal cortices of the
previously asphyxiated animals, concentrations were re-
duced by approximately 50%, and these reductions
reflect an important long-term susceptibility of the
dopaminergic system to asphyxia. Directly related to
these results, both the Bustamante [49] and Chen [50]
groups showed region-specific effects on the basal levels
of DA and metabolites in 4-week-old animals born via
cesarean section (C-section) and subjected to later
immersion in a 37°C water bath. Interestingly, decreased
DA and DOPAC levels were observed in the nucleus
accumbens, a terminal field of the mesolimbic dopamin-
ergic system, in animals asphyxiated for more than
20 min [50]. When the measurements were repeated at
2–3 months after asphyxia in the same group, signifi-
cantly reduced striatal DA and DOPAC levels were ob-
served [16]. The reductions in basal cortical extracellular
DA and DOPAC levels observed in the present work are
consistent with these data. Interestingly, previous studies
have shown that the dendritic trees of neurons obtained
from asphyxiated animals are smaller [51] and that the
structural organizations of the synaptic densities in the
striatal tissue of 45-day-old rats asphyxiated at birth are
altered [17]. Together, these results suggest that PA can
cause alterations that underlie the depletions of basal
extracellular DA and DOPAC concentrations observed
here and in other studies, despite the differences in the
asphyxia induction models used.
When the release of DA was stimulated with 4-AP in
the previously asphyxiated rats, the expected elevations
in the extracellular concentrations of DA and DOPAC
were observed shortly after the 4-AP infusion began.
This drug has an antagonistic effect on voltage-gated po-
tassium channels that delays the repolarization phase of
the action potential and thus facilitates the synaptic re-
lease of neurotransmitters [52]. This drug has been used
to produce seizures in experimental animals [53,54] and
as a therapy in the treatment of multiple sclerosis [55].
Notably, despite the elevated basal DA concentrations in
the animals treated with daily doses of CBZ, the extra-
cellular DA concentrations following 4-AP stimulation
were not different from the baseline at any time. In these
animals, only DOPAC exhibited a transient increase 9–
10 min after 4-AP infusion. CBZ exerts an inhibitory
effect on the frequency of neuronal firing [45] that is medi-
ated through a partial block of voltage-gated sodium
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with calcium-dependent action potentials [26], which may
influence receptor function via structural changes caused
by altered phosphorylation or subunit compositions; simi-
lar (but much more extreme) phenomena have been ob-
served in models of hypoxia/ischemia injury [56-58]. We
speculate that these types of cellular mechanisms are oper-
ating during CBZ treatment (from PD11 to PD30 here) to
alter the stimulated release of DA by 4-AP while maintain-
ing the extracellular concentration of DA without altering
the responses to stimuli. These data are relevant for
pediatric patients with histories of PA and CBZ treatment
for prolonged periods because such histories are likely to
interfere with normal brain function, as has been reported
by other authors [59,60].
Conclusion
In conclusion, PA decreased the extracellular content of
DA (and its principal metabolite, DOPAC) in the frontal
cortex. This release was not fully recovered with CBZ
(moreover, despite the higher DA baseline concentra-
tion, no increase was observed in the DA response to 4-
AP stimuli). The causes of this lack of response require
further study. The limited availability of DA in cortical
brain areas during brain development is more relevant
from the perspective of the wide developmental window
of the dopaminergic system because although DA in-
nervation and receptor expression are present from early
development onwards, the maturation of this system
continues during adolescence, and stable patterns con-
tinue to form until maturity; these processes involve cel-
lular and molecular mechanisms that depend to some
extent on the presence of DA in the extracellular space.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SJLP conceived and design the study, performed the microdialysis procedure
and draft the manuscript; AMV participated in HPLC determinations, and
helped to draft the manuscript; LMC participated in discussion of results
and helped to draft the manuscript. All authors read and approved the
final manuscript.
Support
Universidad de Guadalajara (UDG-218202-2013) and CONACyT
(project 105807).
Received: 23 October 2014 Accepted: 23 January 2015
References
1. Shankaran S. Neonatal encephalopathy: treatment with hypothermia.
J Neurotraum. 2009;26:437–43.
2. Van Handel M, Swaab H, de Vries L, Jongmans M. Long-term cognitive and
behavioral consequences of neonatal encephalopaty following asphyxia: a
review. Eur J Pediatr. 2007;166:645–54.
3. Perna R, Cooper D. Perinatal cyanosis: long-term cognitive sequelae and
behavioral consequences. Appl Neuropsychol Child. 2012;1:48–52.4. Haukvik U, McNeil T, Lange E, Mell I, Dale A, Andreassen O, et al. Pre- and
perinatal hypoxia associated with hippocampus/amygdala volume in bipolar
disorder. Psychol Med. 2014;44:975–85.
5. Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain
dopamine transporter binding in male adolescents with attention-deficit/
Hyperactivity disorder: association between striatal dopamine markers and
motor hyperactivity. Biol Psychiatry. 2005;57:229–38.
6. Limosin F. Neurodevelopmental and environmental hypotheses of negative
symptons of schizophrenia. BMC Psychiatry. 2014;14:88–93.
7. Evans DJ, Levene MI, Tsakmakis M. Anticonvulsants for preventing mortality
and morbidity in full term newborns with perinatal asphyxia. Cochrane
Database Syst Rev. 2007;3:CD001240.
8. Filippi L, Fiorini P, Daniotti M, Catarzi S, Savelli S, Fonda C, et al. Safety and
efficacy of topiramate in neonates with hypoxic ischemia encephalopathy
treated with hypothermia. BMC Pediatr. 2012;14:144–54.
9. Schiering IA, de Haan TR, Niermeijer JM, Koelman JH, Majoie CB, Reneman L,
et al. Correlation between clinical and histologic findings in the human
neonatal hippocampus after perinatal asphyxia. J Neuropathol Exp Neurol.
2014;73:324–34.
10. Wang L, Zuo C, Zhao D, Wu X. Brain distribution and efficacy of
carbamazepine in kainic acid induced seizure in rats. Brain Dev.
2000;22:154–7.
11. Ambrosio A, Soares-da-Silva P, Carvalho CM, Carvalho AP. Mechanisms of
action of carbamazepine and its derivatives, oxcarbamazepine, BIA 2–093
and BIA 2–024. Neurochem Res. 2002;27:121–30.
12. Pavlou E, Gkampeta A, Evangeliou A, Athanasiadou-Piperopoulou F. Benign
epilepsy with centro-temporal spikes (BECTS): relationship between unilateral
or bilateral localization of interictal stereotyped focal spikes on EEG and the
effectiveness of anti-epileptic medication. Hippokratia. 2012;16:221–4.
13. Chen Y, Herrera-Marschitz M, Bjelke B, Blum M, Gross J, Andersson K.
Perinatal asphyxia-induced changes in rat brain tyrosine hydroxylase
immunoreactive cell body number: effects of nicotine treatment.
Neurosci Lett. 1997;221:77–80.
14. Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J,
Andersson K, et al. Perinatal asphyxia induces long-term changes in
dopamine D1, D2 and D3 receptor binding in the rat brain. Exp Neurol.
1997;146:74–80.
15. Gross J, Andersson K, Chen Y, Muller I, Andreeva N, Herrera-Marschitz M.
Effect of perinatal asphyxia on tyrosine hydroxylase and D2 and D1
dopamine receptor mRNA levels expressed during early postnatal
development in rat brain. Mol Brain Res. 2005;134:275–81.
16. Bustamante D, Morales P, Torres-Pereyra J, Goiny M, Herrera-Marschitz M.
Nicotinamide prevents the effect of perinatal asphyxia on dopamine release
evaluated with in vivo microdialysis 3 months after birth. Exp Brain Res.
2007;177:358–69.
17. Cebral E, Loidl CF. Changes in neostriatal and hippocampal synaptic
densities in perinatal asphyctic male and female young rats: Role of
hypothermia. Brain Res Bull. 2011;84:31–8.
18. Decker MJ, Hue GE, Caudle WM, Miller GW, Keating GL, Rye DB. Episodic
neonatal hypoxia evokes executive dysfunction and regionally specific
alterations in markers of dopamine signaling. Neuroscience. 2003;117:417–25.
19. Weitsdoerfer R, Pollak A, Lubec B. Perinatal asphyxia in the rat has lifelong
effects on morphology, cognitive functions, and behavior. Sem Perinatol.
2004;28:249–56.
20. Floresco SB, Magyar O, Ghods-Sharifi S, Vexelman C, Tse MTL. Multiple
dopamine receptor subtype in the medial prefrontal cortex of the rat
regulate set-shifting. Neuropsychophar. 2006;31:297–309.
21. Galeano P, Blanco-Calvo E, Madureira-de-Oliveira D, Cuenya L, Kamenetzy GV,
Mustaca AE, et al. Long-lasting effects of perinatal asphyxia on exploration,
memory and incentive downshift. Int J Dev Neurosci. 2011;29:609–19.
22. Lipkind GM, Fozzard HA. Molecular model of anticonvulsant drug binding
to the voltage-gated sodium channel inner pore. Mol Pharmacol.
2010;78:631–8.
23. Wiffen PJ, Derry S, Moore RA. Kalso EA (2014): Carbamazepine for chronic
neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev.
2014;4, CD005451.
24. Thakkar KB, Jain MM, Billa G, Joshi A, Khobragade AA. A drug utilization
study of psychotropic drugs prescribed in the psychiatry outpatient
department of a tertiary care hospital. J Clin Diagn Res. 2013;7:2759–64.
25. Qiao X, Sun G, Clare JJ, Werkman T, Wadman WJ. Properties of human brain
sodium channel α-subunits expressed in HEK293 cells and their modulation
López-Pérez et al. Journal of Biomedical Science  (2015) 22:14 Page 7 of 7by carbamazepine, phenytoin and lamotrigine. Br J Pharmacol.
2014;171:1054–67.
26. Okada M, Kawata Y, Mizuno K, Wada K, Kondo T, Kaneko S. Interaction
between Ca2+, K+, carbamazepine and zonisamide on hippocampal
extracellular glutamate monitored with a microdialysis electrode. Br J
Pharmacol. 1998;124:1277–85.
27. Sabban EL. Synthesis of dopamine and its regulation. In: Stone TW, editor.
In CNS Neurotransmitters and Neuromodulators. Dopamine. New York: CRC
Press; 1996. p. 1–20.
28. Bahena-Trujillo R, Flores G, Arias-Montaño JA. Dopamina: síntesis, liberación
y receptores en el Sistema Nervioso Central. Rev Biomed. 2000;11:39–60.
29. Nakajima W, Ishida A, Takada G. Effect of anoxia on striatal monoamine
metabolism in immature rat brain compared with that of hypoxia: an
in vivo microdialysis study. Brain Res. 1996;740:316–22.
30. Ogasawara M, Nakajima W, Ishida A, Takada G. Striatal perfusion of
indomethacin attenuates dopamine increase in immature rat brain exposed
to anoxia: an in vivo microdialysis study. Brain Res. 1999;842:487–90.
31. Ungethum U, Chen Y, Gross J, Bjelke B, Bolme P, Eneroth P, et al. Effects of
perinatal asphyxia on the mesostriatal/mesolimbic dopamine system of
neonatal and 4-week-old male rats. Exp Brain Res. 1996;112:403–10.
32. Loidl CF, Herrera-Marschitz M, Andersson K, You ZB, Goiny M, O'Connor WT,
et al. Long-term effects of perinatal asphyxia on basal ganglia neurotransmitter
systems studied with microdialysis in rat. Neurosci Lett. 1994;175:9–12.
33. Kritzer MF, Creutz LM. Region and sex differences in constituent dopamine
neurons and immunoreactivity for intracellular estrogen and androgen
receptors in mesocortical projections in rats. J Neurosci. 2008;28:9525–35.
34. Nikolaus S, Antke C, Muller H. In vivo imaging of synaptic function in the
central nervous system: II. Mental and affective disorders. Behav Brain Res.
2009;204:32–66.
35. Reddy DS. Current pharmacotherapy of attention deficit hyperactivity
disorder. Drugs Today (Barc). 2013;49:647–65.
36. Masana M, Santana N, Artigas F, Bortolozzi A. Dopamine neurotransmission
and atypical antipsychotics in prefrontal cortex: a critical review. Curr Top
Med Chem. 2012;12:2357–74.
37. Jensen F, Wang C. Hypoxia-induced hyperexcitability in vivo and in vitro in
the immature hippocampus. Epilepsy Res. 1996;26:131–40.
38. De Haan M, Wyatt J, Roth S, Vargha-Khadem F, Gadian D, Mishkin M. Brain
and cognitive behavioral development after asphyxia at term birth. Dev
Neurosci. 2006;9:350–8.
39. Faridar A, Bershad EM, Emiru T, Iaizzo PA, Suarez JI, Divani AA. Therapeutic
hypothermia in stroke and traumatic brain injury. Front Neurol.
2011;2:80–93.
40. Jensen F, Wang C, Stafstrom C, Liu Z, Geary C, Stevens M. Acute and
chronic increases in excitability in rat hippocampal slices after perinatal
hypoxia in vivo. J Neurophysiol. 1998;79:73–81.
41. Jensen F. The role of glutamate receptor maturation in perinatal seizures
and brain injury. Int J Devl Neurosci. 2002;20:339–47.
42. López-Pérez SJ, Morales-Villagrán A, Ventura-Valenzuela J, Medina-Ceja L.
Short- and long-term changes in extracellular glutamate and acetylcholine
concentrations in the rat hippocampus following hypoxia. Neurochem Int.
2012;61:258–65.
43. Li C, Jackson R. Reactive species mechanisms of cellular hypoxia-reoxygenation
injury. Am J Cell Physiol. 2002;282:227–41.
44. Salchner P, Engidawork E, Hoeger H, Lubec B, Singewald N. Perinatal
asphyxia exerts lifelong effects on neuronal responsiveness to stress in
specific brain regions in the rat. J Investig Med. 2003;51:288–94.
45. Theile JW, Cummins TR. Inhibition of Navβ4 peptide-mediated resurgent
sodium currents in Nav1.7 channels by carbamazepine, riluzole, and
anandamide. Mol Pharmacol. 2011;80:724–34.
46. Stewart T, Michel A, Black M, Humphrey P. Evidence that nitric oxide causes
calcium-independent release of [3H] Dopamine from rat striatum in vitro.
J Neurochem. 1996;66:137–7.
47. Woodward J, Chandler LJ, Leslie SW. Calcium-dependent and -independent
release of endogenous dopamine from rat striatal synaptosomes. Brain Res.
1998;473:91–8.
48. Olivier V, Gobert A, Guibert B, Leviel V. The in vivo modulation of dopamine
synthesis by calcium ions: influences on the calcium independent release.
Neurochem Int. 1999;35:431–8.
49. Bustamante D, Goiny M, Astrom G, Gross J, Andersson K, Herrera-Marschitz M.
Nicotinamide prevents the long-term effects of perinatal asphyxia on basal
ganglia monoamine systems in the rat. Exp Brain Res. 2003;148:227–32.50. Chen Y, Engidawork E, Loidl F, Dell’Anna E, Goiny M, Lubec G, et al. Short-
and long-term effects of perinatal asphyxia on monoamine, amino acid and
glycolysis product levels measured in the basal ganglia of the rat. Dev Brain
Res. 1997;104:19–30.
51. Klawitter V, Morales P, Johansson S, Bustamante D, Goiny M, Gross J, et al.
Effects of perinatal asphyxia on cell survival, neuronal phenotype and
neurite growth evaluated with organotypic triple cultures. Amino Acids.
2005;28:149–55.
52. Choquet D, Korn H. Mechanism of 4-aminopyridine action on voltage-gated
potassium channels in lymphocites. J Gen Physiol. 1992;99:217–40.
53. Medina-Ceja L, Morales-Villagrán A, Tapia R. Action of 4-aminopyridine on
extracellular amino acids in hippocampus and entorhinal cortex: a dual
microdialysis and electroencehalographic study in awake rats. Brain
Res Bull. 2000;53:255–62.
54. Morales-Villagrán A, Beltrán-Ramírez R, López-Pérez SJ, Palomera-Avalos V,
Medina-Ceja L. A capillary fraction collector coupled to a fluorescence
reader: a novel devide to continuously quantify glutamate during
microdialysis. Neurochem Res. 2012;37:1457–64.
55. Goodman AD, Stone RT. Enhancing neural transmission in multiple sclerosis
(4-aminopyridine therapy). Neurotherapeutics. 2013;10:106–10.
56. Blanco-Suarez E, Hanley JG. Distinct subunit-specific α-Amino-3-hydroxy-5-
methyl-4-isoxazolepropionic Acid (AMPA) receptor trafficking mechanisms
in cultured cortical and hippocampal neurons in response to oxygen and
glucose deprivation. J Biol Chem. 2014;289:4644–51.
57. Tang X, Xing F. Calcium‑permeable AMPA receptors in neonatal
hypoxic‑ischemic encephalopathy (Review). Biomed Reports. 2013;1:828–32.
58. Knox R, Zhao C, Miguel-Pérez D, Wang S, Yuan J, Ferriero D, et al. Enhanced
NMDA receptor tyrosine phosphorylation and increased brain injury following
neonatal hypoxia–ischemia in mice with neuronal Fyn overexpression. Neurobiol
Dis. 2013;51:113–9.
59. García-Peñas JJ, Fournier-del Castillo MC, Domínguez-Carral J. Epilepsia
y cognición: el papel de los fármacos antiepilépticos. Rev Neurol.
2014;58:37–42.
60. Okada M, Hirano T, Mizuno K, Chiba T, Kawata Y, Kiryu K, et al. Biphasic
effects of carbamazepine on the dopaminergic system in rat striatum and
hippocampus. Epilepsy Res. 1997;28:143–53.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
